Innovassynth Technologies Announces Rights Issue of 1.74 Crore Shares at ₹40 Each
Innovassynth Technologies (India) Limited has announced a rights issue of up to 1,74,11,380 fully paid-up equity shares at ₹40 per share, including a premium of ₹30 per share. The issue is being offered to eligible equity shareholders in the ratio of 3 rights equity shares for every 13 fully paid-up equity shares held as on the record date of April 29, 2026. The issue size aggregates up to ₹6,964.55 lakhs, assuming full subscription. The issue opens on May 8, 2026, and closes on May 18, 2026. The company has received in-principle approval from BSE for listing the rights equity shares.

*this image is generated using AI for illustrative purposes only.
Innovassynth Technologies (India) Limited has announced a rights issue of up to 1,74,11,380 fully paid-up equity shares of face value ₹10 each at a price of ₹40 per share, including a premium of ₹30 per share. The issue aggregates up to ₹6,964.55 lakhs, assuming full subscription. The rights issue is being offered to eligible equity shareholders in the ratio of 3 rights equity shares for every 13 fully paid-up equity shares held as on the record date of April 29, 2026.
The company, formerly known as Innovassynth Investments Limited, was incorporated on February 15, 2008. Following a scheme of merger by absorption approved by the National Company Law Tribunal, Mumbai Bench-1 in November 2025, Innovassynth Technologies (India) Limited was merged into the company, and the company was renamed accordingly effective December 31, 2025.
Issue Details
| Particulars | Details |
|---|---|
| Rights Equity Shares Offered | Up to 1,74,11,380 fully paid-up equity shares of ₹10 each |
| Rights Entitlement Ratio | 3 rights equity shares for every 13 equity shares held |
| Issue Price | ₹40 per rights equity share (including premium of ₹30) |
| Issue Size | Up to ₹6,964.55 lakhs |
| Record Date | April 29, 2026 |
| Issue Opening Date | May 8, 2026 |
| Issue Closing Date | May 18, 2026 |
The issue price of ₹40 per rights equity share is four times the face value of the equity shares. The rights equity shares issued pursuant to this issue will rank pari passu in all respects with the existing equity shares of the company.
Issue Schedule
| Event | Date |
|---|---|
| Last Date for Credit of Rights Entitlements | April 30, 2026 |
| Issue Opening Date | May 8, 2026 |
| Last Date for On-Market Renunciation | May 12, 2026 |
| Date of Closure of Off-Market Transfer | May 15, 2026 |
| Issue Closing Date | May 18, 2026 |
| Finalisation of Basis of Allotment | May 19, 2026 |
| Date of Allotment | May 19, 2026 |
| Date of Credit of Rights Equity Shares | May 20, 2026 |
| Date of Listing | May 21, 2026 |
The board of directors or the rights issue committee reserves the right to extend the issue period, not exceeding 30 days from the issue opening date. No withdrawal of applications will be permitted after the issue closing date.
Objects of the Issue
The net proceeds from the issue, estimated at ₹6,882.11 lakhs after deducting issue-related expenses of ₹82.44 lakhs, are proposed to be utilized for the following purposes:
| Sr. No. | Particulars | Amount (₹ in Lakhs) |
|---|---|---|
| 1 | Pre-payment of Rupee Term Loan from ICICI Bank Limited | 4,400 |
| 2 | To augment working capital requirements | 850 |
| 3 | General Corporate Purposes | 1,632.11 |
| Total | 6,882.11 |
The company intends to utilize ₹4,400 lakhs for the full prepayment of the rupee term loan availed from ICICI Bank Limited. The working capital augmentation of ₹850 lakhs will support the company's manufacturing and contract research activities. The amount allocated for general corporate purposes will not exceed 25% of the gross proceeds.
Key Appointments
MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) has been appointed as the registrar to the issue. ICICI Bank Limited is acting as the banker to the issue. ACER Credit Rating Private Limited has been appointed as the monitoring agency to oversee the utilization of the gross proceeds.
The existing equity shares of the company are listed on BSE Limited. The company has received in-principle approval from BSE for listing the rights equity shares to be allotted pursuant to this issue. The designated stock exchange for the issue is BSE Limited.
Historical Stock Returns for Innovassynth Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.21% | +9.13% | +41.36% | +1.10% | +14.97% | +1,274.13% |
How will the debt reduction from ICICI Bank loan prepayment impact Innovassynth's ability to compete for larger contracts in the specialty chemicals and pharmaceutical intermediates market?
What specific expansion plans does Innovassynth have for its Life Sciences vertical, particularly in the growing oligonucleotides manufacturing sector?
Will the improved financial flexibility from reduced debt servicing costs enable Innovassynth to pursue strategic acquisitions or partnerships in the CRDMO space?

































